ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 116 filers reported holding ENZO BIOCHEM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,455,000 | -63.9% | 178,552 | -53.6% | 0.07% | -55.8% |
| Q3 2017 | $4,028,000 | -19.8% | 384,740 | -15.4% | 0.16% | -12.2% |
| Q2 2017 | $5,024,000 | +84.4% | 455,042 | +39.8% | 0.19% | +88.0% |
| Q1 2017 | $2,724,000 | +20.6% | 325,504 | +0.0% | 0.10% | +12.4% |
| Q4 2016 | $2,258,000 | +98.9% | 325,362 | +45.9% | 0.09% | +117.1% |
| Q3 2016 | $1,135,000 | -61.8% | 222,989 | -55.2% | 0.04% | -71.5% |
| Q2 2016 | $2,969,000 | – | 497,291 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |